financetom
Business
financetom
/
Business
/
Quantum BioPharma Gets Health Canada License to Sell Qlarity Supplement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quantum BioPharma Gets Health Canada License to Sell Qlarity Supplement
Sep 18, 2025 6:12 AM

08:43 AM EDT, 09/18/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) said Thursday it has been granted a Health Canada product license for Qlarity, a natural health dietary supplement, allowing it to now be sold in Canada with specific recommendations.

Quantum licensed a similar product, as a dietary supplement, for sale in the United States under the brand name unbuzzd.

"This is a milestone in Quantum BioPharma's ( QNTM ) mission to bring innovative products to the market", said chief executive Zeeshan Saeed. "We can now sell Qlarity to the Canadian market, leveraging its significant potential to improve consumer well-being."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Magnite to Provide Programmatic Ad Sales Support to X
Market Chatter: Magnite to Provide Programmatic Ad Sales Support to X
Feb 7, 2025
02:19 PM EST, 02/07/2025 (MT Newswires) -- Magnite ( MGNI ) is collaborating with Elon Musk's X to boost the social media platform's programmatic advertising sales, Business Insider reported Friday, citing Magnite's ( MGNI ) spokesperson. The partnership gives advertisers an option to add or remove X's inventory from their media buys, the spokesperson reportedly said. Neither Magnite ( MGNI...
JPMorgan appoints co-heads of commercial banking Sable and Smith
JPMorgan appoints co-heads of commercial banking Sable and Smith
Feb 7, 2025
NEW YORK, Feb 7 (Reuters) - JPMorgan Chase ( JPM ) appointed Matt Sable and Melissa Smith as co-heads of commercial banking, the largest U.S. lender said on Friday, as it continues to reorganize the unit. The move follows a broader leadership reshuffle last month in which Jennifer Piepszak was named as chief operating officer to succeed Daniel Pinto. ...
Gatx Insider Sold Shares Worth $349,948, According to a Recent SEC Filing
Gatx Insider Sold Shares Worth $349,948, According to a Recent SEC Filing
Feb 7, 2025
01:53 PM EST, 02/07/2025 (MT Newswires) -- John Sbragia, Senior Vice President, Engineering and Quality, on February 06, 2025, sold 2,100 shares in Gatx ( GATX ) for $349,948. Following the Form 4 filing with the SEC, Sbragia has control over a total of 7,051 common shares of the company, with 7,051 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/40211/000156218025001010/xslF345X05/primarydocument.xml Price: 165.05,...
AbbVie Says FDA Approves Emblaveo Antibiotic to Treat Abdominal Infections
AbbVie Says FDA Approves Emblaveo Antibiotic to Treat Abdominal Infections
Feb 7, 2025
02:03 PM EST, 02/07/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it received approval from the US Food and Drug Administration for its antibiotic Emblaveo for the treatment of adults with complicated intra-abdominal infections. The approval covers Emblaveo's use with metronidazole in patients who have limited or no alternative options to treat their infections, including those caused by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved